Search references
Search results
-
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.
Source: J Am Acad Dermatol. 2004 Jun;50(6):859-66. DOI: 10.1016/j.jaad.2003.09.014 Language: English Availability: abstract -
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.
Source: J Rheumatol. 1997 Apr;24(4):799-802. DOI: Not specified Language: English Availability: full text